Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BACK IMAC	$0.07 -18.2%	$0.06	$0.03 ▼ $1.92	$149K	2.19	614,226 shs	1,088 shs
BTTX Better Therapeutics	$0.00	$0.00	$0.00 ▼ $0.00	$5K	0.97	15,483 shs	6,092 shs
OTRK Ontrak	$0.07 +12.0%	$0.57	$0.05 ▼ $0.10	$422K	1.97	364,107 shs	153,213 shs
UPHL UpHealth	$0.00	$0.00	$0.00 ▼ $0.41	$4K	0.85	5,903 shs	10 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BACK IMAC	-18.18%	+1.41%	+10.77%	+118.18%	-96.33%
BTTX Better Therapeutics	0.00%	0.00%	0.00%	0.00%	0.00%
OTRK Ontrak	+11.99%	-78.48%	-88.17%	-95.48%	-97.99%
UPHL UpHealth	0.00%	0.00%	0.00%	-33.33%	-99.95%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BACK IMAC	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BTTX Better Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OTRK Ontrak	1.7947 of 5 stars	3.5	2.0	0.0	0.0	0.6	0.0	1.3
UPHL UpHealth	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BACK IMAC	0.00	N/A	N/A	N/A
BTTX Better Therapeutics	0.00	N/A	N/A	N/A
OTRK Ontrak	3.00	Buy	$3.00	4,125.35% Upside
UPHL UpHealth	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest BACK, OTRK, BTTX, and UPHL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
7/9/2025	OTRK Ontrak	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$4.00 ➝ $3.00

(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BACK IMAC	$72.05K	2.07	N/A	N/A	($0.66) per share	-0.11
BTTX Better Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A
OTRK Ontrak	$10.18M	0.03	N/A	N/A	$2.34 per share	0.03
UPHL UpHealth	$130M	0.00	N/A	N/A	$3.10 per share	0.00

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BACK IMAC	-$9.42M	N/A	0.00	∞	N/A	N/A	N/A	-325.44%	11/3/2025 (Estimated)
BTTX Better Therapeutics	-$39.76M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
OTRK Ontrak	-$25.49M	-$15.81	N/A	N/A	N/A	-274.20%	-269.88%	-128.35%	11/11/2025 (Estimated)
UPHL UpHealth	-$56.42M	-$1.35	N/A	∞	N/A	N/A	N/A	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BACK IMAC	N/A	N/A	N/A	N/A	N/A
BTTX Better Therapeutics	N/A	N/A	N/A	N/A	N/A
OTRK Ontrak	N/A	N/A	N/A	N/A	N/A
UPHL UpHealth	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BACK IMAC	N/A	0.08	0.08
BTTX Better Therapeutics	N/A	N/A	N/A
OTRK Ontrak	0.54	0.72	0.72
UPHL UpHealth	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BACK IMAC	5.84%
BTTX Better Therapeutics	34.00%
OTRK Ontrak	12.95%
UPHL UpHealth	56.10%

Insider Ownership

Company	Insider Ownership
BACK IMAC	12.26%
BTTX Better Therapeutics	51.40%
OTRK Ontrak	1.90%
UPHL UpHealth	34.24%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BACK IMAC	180	2.07 million	1.82 million	Not Optionable
BTTX Better Therapeutics	40	49.86 million	24.23 million	Optionable
OTRK Ontrak	250	4.22 million	4.14 million	No Data
UPHL UpHealth	1,750	18.93 million	12.45 million	No Data

BACK, OTRK, BTTX, and UPHL Headlines

Recent News About These Companies

UpHealth Delays Q2 2025 10-Q Filing

August 14, 2025 | msn.com

UpHealth, Inc. (UPHL) Latest Stock News & Headlines - Yahoo Finance

April 23, 2025 | finance.yahoo.com

Lemon Dump Cake Recipe

September 9, 2024 | msn.com

DJUSIV Dow Jones US Business Support Services Index

July 27, 2024 | seekingalpha.com

UpHealth Inc Ordinary Shares UPHL

July 19, 2024 | morningstar.comM

UpHealth Holdings, Inc. Wins Ruling in Calcutta High Court, Mandating All Glocal Healthcare Respondents Submit Affidavits of Assets

May 24, 2024 | prnewswire.com

UpHealth, Inc. (UPHL) Advances While Market Declines: Some Information for Investors

April 30, 2024 | zacks.com

UpHealth, Inc. (UPHL)

April 17, 2024 | finance.yahoo.com

Calcutta High Court rules in favour of UpHealth Holdings, Inc., and vigorously reinforces the ICC International Court of Arbitration previous $110 million award against Glocal directors and other Respondents, calling their conduct “dishonest and fraudulent”

April 16, 2024 | finance.yahoo.com

UpHealth Holdings Takes Steps to Enforce the International Court of Arbitration’s Final Award to UpHealth Holdings of more than $110 Million in Damages in Breach of Contract Lawsuit Involving the 2020 Purchase by UpHealth of Glocal Healthcare Systems

April 1, 2024 | finance.yahoo.com

UpHealth, Inc.: UpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial Results

March 22, 2024 | finanznachrichten.de

UpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial Results

March 21, 2024 | finance.yahoo.com

Healthcare Triangle GAAP EPS of -$1.26, revenue of $7.1M

March 18, 2024 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BACK, OTRK, BTTX, and UPHL Company Descriptions

IMAC NASDAQ:BACK

$0.07 -0.02 (-18.18%)

As of 08/22/2025 10:27 AM Eastern

IMAC Holdings, Inc. owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides medical treatments, regenerative, spinal decompression, chiropractic manipulation, and physical medicine and therapy. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Franklin, Tennessee.

Better Therapeutics NASDAQ:BTTX

$0.0001 0.00 (0.00%)

As of 08/22/2025 02:10 PM Eastern

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

Ontrak NASDAQ:OTRK

$0.07 +0.01 (+11.99%)

As of 08/22/2025 03:53 PM Eastern

Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.

UpHealth NYSE:UPHL

$0.0002 0.00 (0.00%)

As of 08/22/2025

UpHealth, Inc. provides behavioral health solutions through the utilization of evidence-based treatments and services in the Americas. The company offers mental health and substance use disorder treatment services directly to consumers. It also provides detoxification, residential, partial hospitalization program, intensive outpatient program, outpatient services, and non-clinical recovery residence and supporting housing services. UpHealth, Inc. is headquartered in Delray Beach, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time